Mindboggling: UK Doctors Destroy Breast Cancer Tumors in Just 11 Days — WITHOUT Chemotherapy

Posted by on January 9, 2018 in Healing & Natural Remedies, Health with 0 Comments

breast-cancer

By Vandita | We Are Anonymous

A team of doctors from Manchester University, Edinburgh University, and The Institute of Cancer Research in London have developed a new two-pronged treatment for a particularly aggressive form of breast cancer that makes tumors disappear in just 11 days. On top of the medical breakthrough, it spares thousands of women across the world from the bone-chillingly painful chemotherapy.

Cancer surgeon Dr. Nigel Bundred, who is professor of surgical oncology at the University of Manchester and the University Hospital of South Manchester NHS Foundation Trust, described the unexpected results from the UK EPHOS-B multi-centre clinical trial as ‘staggering,’ at the 10th European Breast Cancer Conference (EBCC-10) in Amsterdam.


Although Dr. Nigel cautioned that they would need to carry out further trials to confirm the results, he could barely contain himself over the treatment’s ground-breaking potential.

Related Article: The True History of Chemotherapy & The Pharmaceutical Monopoly

For solid tumors to disappear in 11 days is unheard of. These are mind-boggling results. We are pretty certain that we are not only getting tumor disappearance – we are getting an immune response as well. These results are so staggering that I suspect we will have to run another trial to prove that they are generalisable.”

257 women, who had been diagnosed with the HER2 positive breast cancer (HER2 positive breast cancers tend to divide and grow more quickly than HER2 negative breast cancers) with tumors between 1 and 3 cm in size, were recruited between November 2010 and September 2015. Out of these 257 women, 66 were treated with a combination of the targeted drugs Lapatinib (sold under the brand name Tyverb) and Trastuzumab (sold under the brand name Herceptin) straight after diagnosis but before surgery and chemotherapy, across 23 UK hospitals.

The results were dramatic, to say the least: 87% of women with HER2 positive breast cancers responded to the treatment, with tests showing that the cancer had stopped producing more cells. Out of these 87%, 11% of the tumors were completely destroyed; the tumors in a further 17% shrunk to less than 5mm in diameter. Dr. Nigel remarked:


“This has ground-breaking potential because it allows us to identify a group of patients who, within 11 days, have had their tumors disappear with anti-HER2 therapy alone and who potentially may not require subsequent chemotherapy. This offers the opportunity to tailor treatment for each individual woman.”

Breast cancer

Professor Judith Bliss, director of the Cancer Research UK funded Clinical Trials and Statistics Unit (ICR-CTSU), told reporters at EBCC-10:

“These results show that we can get an early indication of pathological response within 11 days, in the absence of chemotherapy, in these patients on combination treatment. Most previous trials have only looked at the pathological response after several months of treatment. Clearly these results need further confirmation, but I suspect the excitement from seeing the speed of disappearance of the tumors will mean that several trials will attempt to confirm these results.”

Herceptin is used after surgery, alongside chemotherapy, to stop HER2 positive breast cancer from returning. Tyverb is used when the HER2 positive breast cancer spreads to other parts of the body. While Herceptin targets the surface of cancer cells, Tyverb penetrates the cancer cells and attacks from within. By giving the combination right after diagnosis, the doctors found they could eradicate HER2 positive breast cancer at the very beginning. Women may still have to undergo surgery, to make sure no cancer cells are left, but they may not have to undergo chemotherapy afterwards.

Samia al Qadhi, chief executive at UK-based charity Breast Cancer Care, noted:

“The astonishing findings in this study show that combining these two drugs has the potential to shrink HER2 positive breast cancer in just 11 days. For some HER2 positive breast cancer patients the effect of this drug combination will be amazing, and mean they can avoid chemotherapy and its grueling side effects completely. For others, their tumors may not shrink, but doctors will know either way very quickly, giving them the ability to rapidly decide on further treatment. Although an early study, this has game changing potential.”

In 2016, an estimated 246,660 new cases of invasive breast cancer are expected to be diagnosed in the United States alone, along with 61,000 new cases of non-invasive breast cancer; shockingly, about 40,450 American women are expected to die in 2016 from breast cancer. In the United Kingdom, 15% to 25% of women diagnosed with breast cancer have HER2, a total of 5,300 to 8,000 women a year.

Professor Arnie Purushotham, senior clinical adviser at Cancer Research UK, observed:

These results are very promising if they stand up in the long run and could be the starting step of finding a new way to treat HER2 positive breast cancers. This could mean some women can avoid chemotherapy after their surgery – sparing them the side-effects and giving them a better quality of life.”

Related Article: Berkeley Doctor Claims People Die From Chemotherapy, Not Cancer [Watch]

This article (Mindboggling: UK Doctors Destroy Breast Cancer Tumors in Just 11 Days — WITHOUT Chemotherapy) is a free and open source. You have permission to republish this article under a Creative Commons license with attribution to the author and AnonHQ.com.

Read more great articles at We Are Anonymous.

Tags: , , , ,

Subscribe

If you enjoyed this article, subscribe now to receive more just like it.

Subscribe via RSS Feed Connect on YouTube

New Title

NOTE: Email is optional. Do NOT enter it if you do NOT want it displayed.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

FAIR USE NOTICE. Many of the articles on this site contain copyrighted material whose use has not been specifically authorized by the copyright owner. We are making this material available in an effort to advance the understanding of environmental issues, human rights, economic and political democracy, and issues of social justice. We believe this constitutes a 'fair use' of the copyrighted material as provided for in Section 107 of the US Copyright Law which contains a list of the various purposes for which the reproduction of a particular work may be considered fair, such as criticism, comment, news reporting, teaching, scholarship, and research. If you wish to use such copyrighted material for purposes of your own that go beyond 'fair use'...you must obtain permission from the copyright owner. And, if you are a copyright owner who wishes to have your content removed, let us know via the "Contact Us" link at the top of the site, and we will promptly remove it.

The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Conscious Life News assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms.

Paid advertising on Conscious Life News may not represent the views and opinions of this website and its contributors. No endorsement of products and services advertised is either expressed or implied.
Top

Send this to friend